hotspot -WSS

hotspot

author：Wikipedia 2025-09-28 08:53:49 - browse：76615

Boxes of Ozempic photo illustration. -- health coverage from STAT — Mario Tama/Getty Images

LONDON — Novo Nordisk’s diabetes medication Ozempic cut the risk of patients developing advanced kidney disease or dying from kidney or heart complications, the company said Tuesday, adding to the evidence the wildly popular drug has broader health benefits for patients beyond addressing their diabetes.

Overall, Ozempic lowered the risk of progression of patients’ kidney disease and of related health events by 24% versus placebo, according to the topline results. The company, which will present full data from the study later this year, said it would file for an expanded approval of Ozempic based on the data in both the U.S. and Europe.

The positive announcement had been expected since October, when Novo announced it was ending the FLOW trial early because an interim data analysis showed the drug was surpassing the study’s goals. Still, the results provide an important data point for Novo both as its medicines face increasing competition and as it tries to get more insurers to cover its related obesity drug Wegovy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Novo Nordisk testing Wegovy against alcohol

focus

WSS

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

Free medical tuition alone isn't enough to close gaps in primary care

Malaysia cuts short music fest after British band slams anti

Cherokee Nation medical school graduates its first class

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Men with early prostate cancer can safely opt out of treatment

leisure time

hotspot

leisure time

Apple is now the first public company to be valued at $3 trillion

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Anesthesiologist group: stop taking Ozempic before surgery

How to protect coverage of PrEP

Guidelines to prevent youth baseball injuries need more muscle

Hottest summer in 2,000 years puts focus on extreme heat, health

BioMarin wins approval for gene therapy to treat hemophilia A

Free medical tuition alone isn't enough to close gaps in primary care

Supreme Court strikes down use of affirmative action

The White House hikes tariffs on plastic syringes made in China

hotspot

Supreme Court to hear if Covid misinformation is protected speech

Transgender women dream of pregnancy via uterus transplants

Lilly’s weekly insulin works as well as daily products, new studies show

As H5N1 spreads in cows, experts warn against drinking raw milk

How a key Senate committee is planning to regulate PBMs

HHS suspends federal funding for EcoHealth Alliance

hotspot

hotspot

focus

hotspot